Your browser doesn't support javascript.
loading
Fingolimod suppresses bone resorption in female patients with multiple sclerosis.
Miyazaki, Yusei; Niino, Masaaki; Kanazawa, Ippei; Suzuki, Masako; Mizuno, Masanori; Hisahara, Shin; Fukazawa, Toshiyuki; Takahashi, Eri; Amino, Itaru; Ochi, Ryutaro; Nakamura, Masakazu; Akimoto, Sachiko; Minami, Naoya; Fujiki, Naoto; Doi, Shizuki; Shimohama, Shun; Terayama, Yasuo; Kikuchi, Seiji.
Afiliação
  • Miyazaki Y; Department of Clinical Research, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan. Electronic address: yuseimiyazaki@hok-mc.hosp.go.jp.
  • Niino M; Department of Clinical Research, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Kanazawa I; Department of Internal Medicine 1, Shimane University Faculty of Medicine, 89-1 Enyacho, Izumo 693-8501, Japan.
  • Suzuki M; Division of Neurology and Gerontology, Department of Internal Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan.
  • Mizuno M; Division of Neurology and Gerontology, Department of Internal Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan.
  • Hisahara S; Department of Neurology, Sapporo Medical University School of Medicine, Minami-1-jo Nishi-17-chome, Chuo-ku, Sapporo 060-8556, Japan.
  • Fukazawa T; Sapporo Neurology Clinic, 2-17 Kita-21-jo Higashi-21-chome, Higashi-ku, Sapporo 065-0021, Japan.
  • Takahashi E; Department of Clinical Research, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Amino I; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Ochi R; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Nakamura M; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Akimoto S; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Minami N; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Fujiki N; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Doi S; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
  • Shimohama S; Department of Neurology, Sapporo Medical University School of Medicine, Minami-1-jo Nishi-17-chome, Chuo-ku, Sapporo 060-8556, Japan.
  • Terayama Y; Division of Neurology and Gerontology, Department of Internal Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan.
  • Kikuchi S; Department of Neurology, Hokkaido Medical Center, 1-1 Yamanote 5-jo 7-chome, Nishi-ku, Sapporo 063-0005, Japan.
J Neuroimmunol ; 298: 24-31, 2016 09 15.
Article em En | MEDLINE | ID: mdl-27609272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reabsorção Óssea / Caracteres Sexuais / Cloridrato de Fingolimode / Imunossupressores / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reabsorção Óssea / Caracteres Sexuais / Cloridrato de Fingolimode / Imunossupressores / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article